Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial

Guillem Argilés, Mark P. Saunders, Fernando Rivera, Alberto Sobrero, Al Benson, Carmen Guillén Ponce, Stefano Cascinu, Eric Van Cutsem, Iain R. MacPherson, Dirk Strumberg, Claus Henning Köhne, John Zalcberg, Andrea Wagner, Vittorio Luigi Garosi, Julia Grunert, Josep Tabernero, Fortunato Ciardiello

Research output: Contribution to journalArticleResearchpeer-review

35 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial'. Together they form a unique fingerprint.

Nursing and Health Professions

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Neuroscience